相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy
Balamayoora Theivanthiran et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Targeting off-target effects: endoplasmic reticulum stress and autophagy as effective strategies to enhance temozolomide treatment
Yichun He et al.
ONCOTARGETS AND THERAPY (2019)
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
CARD9 inhibits mitochondria-dependent apoptosis of cardiomyocytes under oxidative stress via interacting with Apaf-1
Yuanbin Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance
Aaron Goldman et al.
SCIENCE SIGNALING (2019)
The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries
Patrick S. Mitchell et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability
Alice Raineri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
Junseong Park et al.
ONCOIMMUNOLOGY (2019)
Drug resistance and combating drug resistance in cancer
Xuan Wang et al.
CANCER DRUG RESISTANCE (2019)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
ATF4-dependent regulation of vemurafenib resistance in melanoma by NLRP1
Z. Zhai et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1
Heike Niessner et al.
EXPERIMENTAL DERMATOLOGY (2017)
The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma
Xiaodong Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma
Z. Zhai et al.
ONCOGENE (2017)
Phenotype characterization of human melanoma cells resistant to dabrafenib
Fabiola Gilda Cordaro et al.
ONCOLOGY REPORTS (2017)
New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone
Siwen Hu-Lieskovan et al.
CANCER JOURNAL (2017)
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
Sapna P. Patel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism
X. Chang et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2017)
Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro
Oxana O. Ryabaya et al.
ANTI-CANCER DRUGS (2017)
Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation
Franklin L. Zhong et al.
CELL (2016)
DNA repair mechanisms and their clinical impact in glioblastoma
Helene Erasimus et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)
ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis
Jessica L. Weatherbee et al.
ONCOTARGET (2016)
Targeting inflammasome/IL-1 pathways for cancer immunotherapy
Beichu Guo et al.
SCIENTIFIC REPORTS (2016)
Notch signaling: An emerging therapeutic target for cancer treatment
Xun Yuan et al.
CANCER LETTERS (2015)
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide
Oihane Erice et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Therapy-induced tumour secretomes promote resistance and tumour progression
Anna C. Obenauf et al.
NATURE (2015)
NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
Xuan Wang et al.
ONCOLOGY LETTERS (2015)
Transcription Factor ATF4 Induces NLRP1 Inflammasome Expression during Endoplasmic Reticulum Stress
Andrea D'Osualdo et al.
PLOS ONE (2015)
JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression
Masashi Okada et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Systematic identification of signaling pathways with potential to confer anticancer drug resistance
Colin A. Martz et al.
SCIENCE SIGNALING (2014)
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Dinesh Vyas et al.
ONCOTARGETS AND THERAPY (2014)
ATM Regulates 3-Methylpurine-DNA Glycosylase and Promotes Therapeutic Resistance to Alkylating Agents
Sameer Agnihotri et al.
CANCER DISCOVERY (2014)
Inflammasomes in cancer: a double-edged sword
Ryan Kolb et al.
PROTEIN & CELL (2014)
In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies
Martina McDermott et al.
FRONTIERS IN ONCOLOGY (2014)
Interleukins in glioblastoma pathophysiology: implications for therapy
Y. T. Yeung et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The Notch signaling pathway as a mediator of tumor survival
Kathleen M. Capaccione et al.
CARCINOGENESIS (2013)
Inflammasome and cytokine blocking strategies in autoinflammatory disorders
Monika Moll et al.
CLINICAL IMMUNOLOGY (2013)
Treating inflammation by blocking interleukin-1 in humans
Charles A. Dinarello et al.
SEMINARS IN IMMUNOLOGY (2013)
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P. Godwin et al.
FRONTIERS IN ONCOLOGY (2013)
Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma
Jahan S. Khalili et al.
CLINICAL CANCER RESEARCH (2012)
Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance
Yuchun Luo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug
Simona Caporali et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Role of Notch and its oncogenic signaling crosstalk in breast cancer
Shanchun Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
The role of PARP in DNA repair and its therapeutic exploitation
M. Javle et al.
BRITISH JOURNAL OF CANCER (2011)
Measurements of Tumor Cell Autophagy Predict Invasiveness, Resistance to Chemotherapy, and Survival in Melanoma
Xiao-Hong Ma et al.
CLINICAL CANCER RESEARCH (2011)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
Miyako Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Acquired Resistance to Temozolomide in Glioma Cell Lines: Molecular Mechanisms and Potential Translational Applications
Jihong Zhang et al.
ONCOLOGY (2010)
Notch Promotes Radioresistance of Glioma Stem Cells
Jialiang Wang et al.
STEM CELLS (2010)
Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53
S. C. Naumann et al.
BRITISH JOURNAL OF CANCER (2009)
被撤回的出版物: Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma (Retracted Article. See vol 15, pg 3240, 2009)
Christina K. Augustine et al.
CLINICAL CANCER RESEARCH (2009)
Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide
Tobias Sinnberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Mechanisms of chemoresistance to alkylating agents in malignant glioma
Jann N. Sarkaria et al.
CLINICAL CANCER RESEARCH (2008)
Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O-6-methylguanine-DNA methyltransferase in human melanoma cells
Mingzhong Zheng et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation
Benjamin Faustin et al.
MOLECULAR CELL (2007)
Acquired chemoresistance in pancreatic carcinoma cells:: induced secretion of IL-1β and NO lead to inactivation of caspases
S. Sebens Mueerkoester et al.
ONCOGENE (2006)
Notch1 augments NF-κB activity by facilitating its nuclear retention
HM Shin et al.
EMBO JOURNAL (2006)
分享论文
